Improvement in Liver Pathology of Patients With β-Thalassemia Treated With Deferasirox for at Least 3 Years
Keywords: نمره کل آهن; Liver Disease; Clinical Trial; Cirrhosis; Therapy; ALT; alanine aminotransferase; DFO; deferoxamine; dw; dry weight; EOS; end of study; HCV; hepatitis C virus; HIS; hepatocytic iron score; LIC; liver iron concentration; LPI; labile plasma iron; PIS; porta